









Markets
/
Stocks
/
nasdaq-alc
/

Alcon AG

ALC

81.150USD

+0.730+0.91%

Close 01/29, 16:00（ET）Quotes delayed by 15 min

40.14BMarket Cap

38.33P/E TTM



Alcon AG

81.150

+0.730+0.91%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Alcon AG

Currency: USD Updated: 2026-01-29

Key Insights

Alcon AG's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 93.70.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Alcon AG's Score

Industry at a Glance

Industry Ranking

4 / 205

Overall Ranking

54 / 4540

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Alcon AG Highlights

StrengthsRisks

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 9.91B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 15.23%.

Undervalued

The company’s latest PE is 38.33, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 342.44M shares, increasing 0.15% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 1.26.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

93.701

Target Price

+15.87%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-29

The current financial score of Alcon AG is 9.11, ranking 14 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 2.61B, representing a year-over-year increase of 6.52%, while its net profit experienced a year-over-year increase of 9.89%.

Score

Industry at a Glance

Previous score

9.11

Change



Financials

8.30

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.82

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.66

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.38

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.39

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Alcon AG's Company Valuation

Currency: USD Updated: 2026-01-29

The current valuation score of Alcon AG is 6.70, ranking 159 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 38.33, which is 207.97% below the recent high of 118.05 and 13.30% above the recent low of 33.23.

Score

Industry at a Glance

Previous score

6.70

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 4/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-29

The current earnings forecast score of Alcon AG is 7.90, ranking 107 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 95.85, with a high of 112.00 and a low of 80.00.

Score

Industry at a Glance

Previous score

7.90

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

93.701

Target Price

+15.87%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Alcon AG

ALC

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

Medtronic PLC

MDT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-29

The current price momentum score of Alcon AG is 8.95, ranking 30 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 83.52 and the support level at 77.76, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.69

Change

0.26

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.041

Buy

RSI(14)

55.418

Neutral

STOCH(KDJ)(9,3,3)

67.670

Neutral

ATR(14)

1.575

Low Volatility

CCI(14)

59.267

Neutral

Williams %R

23.267

Buy

TRIX(12,20)

0.057

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

80.704

Buy

MA10

80.389

Buy

MA20

80.224

Buy

MA50

79.373

Buy

MA100

77.590

Buy

MA200

82.824

Sell

Institutional Confidence

Currency: USD Updated: 2026-01-29

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Advisors (UK) Limited

24.68M

The Vanguard Group, Inc.

Star Investors

20.97M

+1.56%

UBS Fund Management (Switzerland) AG

11.47M

-0.60%

Norges Bank Investment Management (NBIM)

11.35M

-10.12%

Aristotle Capital Management, LLC

10.71M

-11.06%

T. Rowe Price Associates, Inc.

Star Investors

10.26M

+46.89%

AKO Capital LLP

7.97M

+3.38%

Zürcher Kantonalbank (Asset Management)

8.49M

-7.10%

Fidelity Management & Research Company LLC

7.45M

-27.02%

Select Equity Group, L.P.

6.73M

-0.51%

Risk Assessment

Currency: USD Updated: 2026-01-29

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Alcon AG is 9.54, ranking 8 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.02. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.